Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing, 2020: France, Germany, Italy, Spain, UK - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 27, 2020--
The “2020 Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: France, Germany, Italy, Spain, UK - Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies” report has been added to ResearchAndMarkets.com’s offering.
The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.
This new five-country study from the author contains 495 pages, 28 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
European Market Overview
Market Segmentation Analysis
Opportunities and Strategic Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/ptq4xn
View source version on businesswire.com:https://www.businesswire.com/news/home/20200127005351/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 01/27/2020 08:20 AM/DISC: 01/27/2020 08:20 AM